​

ANI Pharmaceuticals Ownership | Who Owns ANI Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

ANI Pharmaceuticals Ownership Summary

ANI Pharmaceuticals is owned by 18.54% institutional investors, 10.06% insiders, and 71.40% retail investors. Blackrock is the largest institutional shareholder, holding 13.91% of ANIP shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.67% of its assets in ANI Pharmaceuticals shares.

ANIP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockANI Pharmaceuticals18.54%10.06%71.40%
SectorHealthcare Stocks 42.54%10.82%46.64%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.66M13.91%$169.17M
Blackrock funding, inc. /de2.55M12.85%$233.48M
Vanguard group1.28M6.44%$117.02M
Millennium management1.00M5.17%$55.44M
State street711.71K3.59%$65.19M
Global alpha capital management630.59K3.18%$57.76B
Ubs group589.87K2.97%$54.03M
Dimensional fund advisors lp505.43K2.55%$46.30M
Geode capital management458.01K2.31%$41.96M
Deep track capital, lp450.00K2.27%$41.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Apis capital advisors164.00K3.32%$15.02M
Global alpha capital management630.59K3.30%$57.76B
Decker retirement planning36.94K1.86%$3.38M
Lisanti capital growth82.55K1.85%$7.56M
Ranger investment management271.35K1.73%$24.86M
Soleus capital management340.24K1.57%$31.17M
Marathon capital management69.70K1.46%$6.38M
Sio capital management55.72K1.29%$5.10M
Deep track capital, lp450.00K1.15%$41.22M
Tang capital management317.50K1.12%$29.08M

Top Buyers

HolderShares% AssetsChange
Millennium management1.00M0.03%473.10K
Point72 asset management399.09K0.06%399.09K
Arrowstreet capital, limited partnership360.18K0.02%360.18K
Soleus capital management340.24K1.57%289.50K
Divisadero street capital management, lp234.22K0.94%234.22K

Top Sellers

HolderShares% AssetsChange
Ranger investment management271.35K1.73%-262.89K
Deep track capital, lp450.00K1.15%-250.00K
Global alpha capital management630.59K3.30%-231.50K
Woodline partners lp---166.45K
Freestone grove partners lp30.68K0.02%-164.53K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management399.09K0.06%399.09K$36.56M
Arrowstreet capital, limited partnership360.18K0.02%360.18K$32.99M
Divisadero street capital management, lp234.22K0.94%234.22K$21.45M
Driehaus capital management78.81K0.05%78.81K$7.22M
Ossiam47.40K0.06%47.40K$4.34M

Sold Out

HolderChange
Mendota financial group-1.00
Financial gravity asset management-1.00
Nelson, van denburg & campbell wealth management group-1.00
Harbour investments-1.00
Cbiz investment advisory services-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202599-55.61%3,677,102-80.25%180.21%49-57.76%29-57.97%
Jun 30, 2025224-2.18%19,142,922-4.15%960.93%1145.56%70-4.11%
Mar 31, 202522911.16%19,974,4243.61%1011.03%11011.11%7220.00%
Dec 31, 2024203-3.33%19,272,0261.94%991.05%98-21.60%5937.21%
Sep 30, 20242091.95%18,894,59324.90%971.55%12516.82%43-30.65%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.01M4.67%-
Vanguard US Total Market Shares ETF588.25K2.73%-
Vanguard Total Stock Mkt Idx Inv587.04K2.70%-13.01K
Pacer US Small Cap Cash Cows 100 ETF549.63K2.62%-1.87K
iShares Russell 2000 ETF439.65K2.03%-
CC&L Global Alpha - Series A375.10K1.73%-7.20K
Ranger Small Cap359.19K1.66%-19.61K
Delaware Ivy Small Cap Growth C336.40K1.60%-
AZ InvestEd Ivy Small Cap Growth E264.83K1.22%-
Macquarie Small Cap Growth C264.83K1.22%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 18, 2025Davis Krista SVP, CHIEF HR OFFICERSell$133.65K
Dec 12, 2025Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$32.93K
Dec 05, 2025TANNENBAUM RENEE P-Sell$146.07K
Nov 13, 2025Walsh Patrick D-Sell$750.90K
Nov 13, 2025Gassert Chad SVP - CORP. DEV. & STRATEGYSell$8.27K

Insider Transactions Trends

DateBuySell
2025 Q4-8
2025 Q3-22
2025 Q2-6
2025 Q1-8
2024 Q4-8

ANIP Ownership FAQ

Who Owns ANI Pharmaceuticals?

ANI Pharmaceuticals shareholders are primarily institutional investors at 18.54%, followed by 10.06% insiders and 71.40% retail investors. The average institutional ownership in ANI Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which ANI Pharmaceuticals falls below.

Who owns the most shares of ANI Pharmaceuticals?

ANI Pharmaceuticals’s largest shareholders are Blackrock (2.66M shares, 13.91%), Blackrock funding, inc. /de (2.55M shares, 12.85%), and Vanguard group (1.28M shares, 6.44%). Together, they hold 33.20% of ANI Pharmaceuticals’s total shares outstanding.

Does Blackrock own ANI Pharmaceuticals?

Yes, BlackRock owns 13.91% of ANI Pharmaceuticals, totaling 2.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 169.17M$. In the last quarter, BlackRock increased its holdings by 125.17K shares, a 4.94% change.

Who is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Apis capital advisors is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 3.32% of its assets in 164K ANI Pharmaceuticals shares, valued at 15.02M$.

Who is the top mutual fund holder of ANI Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ANI Pharmaceuticals shares, with 4.67% of its total shares outstanding invested in 1.01M ANI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools